#Medication

A common allergy medicine widely sold across Thai pharmacies faces growing international safety concerns. Diphenhydramine, best known as Benadryl, is being scrutinized by leading medical experts who warn its risks may outweigh benefits for many users.

Research from top institutions highlights safer alternatives that are particularly suitable for Thai families seeking allergy relief. Data from international studies suggest a shift toward second-generation antihistamines with improved safety profiles.

Diphenhydramine has occupied Thai medicine cabinets since the mid-20th century. In addition to treating seasonal allergies, it is used for insect bites, sleep difficulties, and some cold symptoms. The drug is readily available across Thailand’s network of pharmacies, with many products accessible without prescriptions.

Bipolar disorder, a complex mood disorder marked by dramatic oscillations between depression and mania, affects an estimated 40 million people worldwide. It is a condition that not only tests individuals’ emotional resilience but also challenges the medical community in its search for effective, personalized treatments. In a recent episode of NPR’s podcast Short Wave, a renowned psychiatry professor from Johns Hopkins School of Medicine—herself living with bipolar disorder—opened up about her diagnosis, daily management, and the latest advancements in treatment. Her dual role as scientist and patient offers a rare, deeply personal, and scientific insight into a condition that remains stigmatized and often misunderstood in many societies, including Thailand.

A wave of recent research is challenging long-held beliefs about Attention Deficit Hyperactivity Disorder (ADHD), questioning whether the condition is truly a lifelong, biologically fixed disorder and whether the medical model that has dominated diagnosis and treatment actually serves those affected. With global ADHD diagnosis rates soaring and stimulant prescriptions at record levels—mirrored by rising numbers in Thailand—the debate over what ADHD is and how best to help children and adults affected is more urgent than ever. These new perspectives could have a profound impact not only on clinical practice in the West but on the evolving approach to ADHD in Thailand, where both awareness and skepticism about the condition are growing rapidly.